MeSH tree: D20.215.894.865.450.250
Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using artificial intelligence (AI). The vaccine's key component was designed entirely by AI and has now been ...
Jun 9, 2026
0
4
The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.
Jun 7, 2026
0
92
T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can't easily distinguish cancerous T cells from healthy ones. Now, scientists ...
Mar 10, 2026
0
15
Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the rare but serious condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT).
Jul 8, 2025
0
70
Until recently, human vaccine development has typically taken 10 to 15 years.
Nov 29, 2024
0
20
COVID-19 vaccination seems to have some side effects on the lower urinary tract and overactive bladder in younger adults, according to a study published online June 24 in Frontiers in Medicine.
Aug 1, 2024
0
177
The Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. However, on May 7, 2024, the European Commission announced the vaccine is no longer authorized for use.
May 9, 2024
0
66
Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing COVID vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump in demand.
May 8, 2024
0
32
A study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
May 3, 2024
0
113
Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition that has become the central focus of a class-action lawsuit worth potentially $125 ...
May 1, 2024
0
99
